Lipoprotein(a) has long been recognized as a critical marker for people at risk of cardiovascular disease. However, the health care industry has lacked the tools to tackle the problem.

A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new mothers, and ...